20-F/A: Clearmind Medicine Files Amendment to Annual Report to Include Executive Certifications
20-F/A Amendment
Clearmind Medicine Inc. files an amendment to its annual report on Form 20-F to include certifications from the CEO and CFO as required by the Securities Exchange Act.
Summary
- Clearmind Medicine Inc. is filing Amendment No. 2 to its Annual Report on Form 20-F for the year ended October 31, 2023.
- The amendment is to include certifications pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) and Rule 15d-14(b), signed by the principal executive officer and principal financial officer.
- These certifications were omitted from Amendment No. 1.
- The amendment includes a cover page, explanatory note, Item 19 (as amended), the signature page, and amended exhibits referenced in Item 19.
- The company had 607,337 common shares outstanding as of October 31, 2023.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, indicating standard corporate governance practices. The sentiment is neutral to slightly positive as it demonstrates compliance.
Key Dates
| Date | Description |
|---|---|
| August 18, 2022 | Reference to Articles of Association filing (Form F-1) |
| November 14, 2022 | Reference to Underwriters Warrant, Indemnification Agreement, Stock Option Plan, Subscription Agreement with Medigus Ltd. filings (Form F-1) |
| September 20, 2022 | Reference to Amendment to Subscription Agreement with Medigus Ltd. filing |
| February 3, 2023 | Reference to List of Subsidiaries filing (Form 20-F) |
| March 27, 2023 | Reference to Warrant Agent Agreement filing (Form F-1) |
| March 30, 2023 | Reference to Common Warrant and Pre-Funded Warrant filings (Form F-1) |
| April 6, 2023 | Reference to Placement Agent Agreement filing (Form 6-K) |
| July 17, 2023 | Reference to Placement Agent Agreement, Common Warrant, Pre-Funded Warrant, and Warrant Agent Agreement filings (Form F-1) |
| October 31, 2023 | Fiscal year ended |
| October 31, 2023 | Outstanding shares of common stock: 607,337 |
| January 29, 2024 | Original Annual Report on Form 20-F filed |
| January 29, 2024 | Letter from Saturna Group Chartered Professional Accountants LLP |
| March 18, 2024 | Amendment No. 1 filed |
| March 27, 2024 | Date of Amendment No. 2 filing and certifications |
Keywords
Form 20-F/A, Amendment, Annual Report, Certifications, Clearmind Medicine, SEC Filing, Financial Reporting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.